In contrast to some glucagon receptor antagonists that have been reported to cause liver enzyme abnormalities and elevation in plasma cholesterol and glucagon, the study showed TIX100 improved plasma ...

Retatrutide mimics the effects of naturally occurring gut hormones to improve metabolic health. Stimulating insulin release ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Under the terms of the agreement, OPKO will accept 60% of the development costs, while Entera will shoulder 40%.

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

Produced by the German company Boehringer Ingelheim, alongside Zealand Pharma, Survodutide is an injectable drug that activates both the glucagon and GLP-1 receptors. According to Nature, the drug is ...

Lilly launches Mounjaro in India, offering new option to treat obesity and type 2 diabetes: Our Bureau, Bengaluru Thursday, ...